Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria are successfully released into the bladder, urine will flush out these ...
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.